FDA announced awards for six new clinical trial research grants totaling over $16 million over the next four years. The grants, awarded through the Congressionally-funded Orphan Products Grants Program, enhance the development of medical products for patients with rare diseases.
Read more: FDA awards six grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases